Emeis traded at 14.05 this Monday March 16th, increasing 0.12 or 0.86 percent since the previous trading session. Looking back, over the last four weeks, Emeis gained 7.99 percent. Over the last 12 months, its price rose by 23.22 percent. Looking ahead, we forecast Emeis to be priced at 13.57 by the end of this quarter and at 12.53 in one year, according to Trading Economics global macro models projections and analysts expectations.
Emeis, formerly Orpea SA, is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services and long-term care homes. The Company operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. It operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.